期刊文献+

环氧化酶-2蛋白在结直肠癌中的作用研究进展

Research progress of cyclooxygenase-2 protein in colorectal cancer
暂未订购
导出
摘要 结直肠癌是全世界发病率较高的恶性肿瘤,治疗过程中易发生复发、转移,病死率高,因此分析相关生物学指标在肿瘤进展中的作用机制,对寻找有效靶标治疗结直肠癌具有重要临床意义。环氧化酶(cyclooxygenase,COX)是将花生四烯酸催化为前列腺素的关键酶,包含COX-1、COX-2两种同工酶,其中COX-2为环氧化酶的诱导型,在恶性肿瘤中呈高表达。COX-2高表达可通过促进肿瘤细胞增殖、促进肿瘤血管形成等多种途径促进肿瘤发生。本文就COX-2的结构特征、在结直肠癌中的作用及其抑制剂在肿瘤中的应用作一全面综述。 Colorectal cancer is a malignant tumor with high incidence rate worldwide.It is easy to have a relapse and metastasis during treatment,and the mortality is high.Therefore,it is of great clinical significance to analyze the mechanism of relevant biological indicators in tumor progression for finding effective targets for the treatment of colorectal cancer.Cyclooxygenase(COX)is the key to catalyzing arachidonic acid into prostaglandins,including COX-1 and COX-2 isoenzymes,of which COX-2 is the inducible type of cyclooxygenase,and is highly expressed in malignant tumors.High expression of COX-2 can promote tumorigenesis by enhancing tumor cell proliferation and tumor angiogenesis.Based on this,this paper reviews the structural characteristics of COX-2,its role in colorectal cancer and the application of COX-2 inhibitors in tumors.
作者 毛焕 王长友 MAO Huan;WANG Changyou(Department of Pathology,Tianjin Jizhou District People,s Hospital,Tianjin 301900,China)
出处 《山东第一医科大学(山东省医学科学院)学报》 CAS 2022年第10期797-800,共4页 Journal of Shandong First Medical University & Shandong Academy of Medical Sciences
关键词 结直肠癌 环氧化酶-2 细胞增殖 肿瘤血管形成 colorectal cancer cyclooxygenase-2 cell proliferation tumor angiogenesis
  • 相关文献

参考文献15

二级参考文献96

  • 1李霆.PTEN和MMP-9在胃癌组织中的表达及意义[J].山东医药,2008,48(5):70-72. 被引量:1
  • 2刘慧燕,赵广才,赵谋明.江蓠硫酸酯多糖的体外抗肿瘤和免疫活性研究[J].现代食品科技,2007,23(1):28-29. 被引量:5
  • 3裴锋,张克亮.核因子-κB和环氧合酶-2在胃癌组织中的表达与肿瘤微血管形成的关系[J].华中科技大学学报(医学版),2007,36(3):355-358. 被引量:11
  • 4汤钊猷.肝癌复发转移的研究[J].实用肿瘤杂志,1997,12(1):3-5. 被引量:14
  • 5Tang L,Guan H,Ding X, et al. Modulation of aflatoxin toxicity and biomarkers by lycopene in F344 rats[J]. Toxicol Appl Phar- macol, 2007, 219(1):10-17.
  • 6Ei Khatib A S, Moustafa A M, Abdel-Aziz A A, et al. Ginkgo biloba extract(EGb761) modulates bleomycin-indueed acute lung injury inrats[J]. Tumori, 2001, 87(6):417 422.
  • 7Midorikawa Y, Ishikawa S, Iwanari H, et al. Glypican-3,over-expressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling[J]. Int J Cancer, 2003,103(4) :455-465.
  • 8Kim Y, Sills R C, Houle C D. Overview of the molecular biolo- gy of hepatocellular neoplasms and hepatoblastomas of the mouse liver[J]. Toxicol Pathol, 2005, 33(1) : 175-180.
  • 9Koga H, Sakisaka S, Ohishi M, et al. Expression of cyclooxy genase-2 in human hepatocellular carcinoma: relevance to tumor dedifferentiation[J]. Hepatology, 1999,29 (3) : 688-696.
  • 10Herbst R S, Johnson D H, Mininberg E, et al. Phase Ⅰ / Ⅱ tria evaluating the anti-vascular endothelial growth factor monoclonal antibody bevacizumab in combination with the HER 1/epidermal growth factor receptor tyrosine kinase inhibitor erlotinib for pa- tients with recurrent non-small cell lung cancer[J]. J Clin On- col, 2005, 23(11); 2544-2555.

共引文献90

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部